D A Stevens, G W Jordan, T F Waddell, T C Merigan. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Antibody Formation/drug effectsBlood Cell CountClinical Trials as TopicComplement Fixation TestsCytarabine/administration & dosageCytarabine/adverse effectsCytarabine/bloodCytarabine/pharmacologyCytarabine/therapeutic useHerpes Zoster/complicationsHerpes Zoster/drug therapyHerpes Zoster/pathologyHerpesvirus 3, Human/immunologyHodgkin Disease/complicationsHumansInfusions, ParenteralInterferons/analysisLymphoma/complicationsLymphoma/immunologyPlacebosTime Factors
Substances: See more » PlacebosCytarabineInterferons
Year: 1973 PMID: 4354007 DOI: 10.1056/NEJM197310252891701
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245